MENU
SLS
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.45
Change
-$0.04 (-2.68%)
Capitalization
219.69M
120 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SLS is expected to report earnings to rise 44.50% to -8 cents per share on March 13

SELLAS Life Sciences Group SLS Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.04
The last earnings report on November 12 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 2.18M shares outstanding, the current market capitalization sits at 219.69M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SLS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLS showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SLS
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com